EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieOpen Access · CC BY-NC 4.0

Changes to insulin requirements over time with semaglutide in adults with type 1 diabetes on insulin pump therapy: A post‐hoc analysis of a double‐blinded, randomised, crossover trial

Melissa-Rosina Pasqua iD, Michael A Tsoukas iD, Ahmad Haidar iD

Diabetes, Obesity and Metabolism · 2026-01 · 28 (1) · 427-433

DOI: 10.1111/dom.70213 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Diabetes, Obesity and Metabolism, online erschienen am 27.10.2025. Verfasst von Melissa-Rosina Pasqua und 2 weiteren Autor:innen. Beteiligte Einrichtung: Division of Endocrinology & Metabolism, McGill University Health Centre, Montreal, Quebec, Canada. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 1, Insulin Infusion Systems, Glucagon-Like Peptides, Hypoglycemic Agents. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Canada Research Chairs.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

There is little data on how semaglutide affects basal versus bolus insulin and dosing parameters in adults with type 1 diabetes on insulin pump therapy.

Methods

This is a post‐hoc analysis of a double‐blinded, randomised, crossover trial assessing semaglutide (up to 1 mg) versus placebo during automated insulin delivery (AID). This analysis focuses on the first 11 of 15 weeks where participants used their routine pump therapy with continuous glucose monitoring (CGM), where remote follow‐ups were performed on days 7, 21, 32, 56, 63, and 77 (± 4 days). Changes in insulin requirements, carbohydrate input, and pump parameters over time compared to baseline were assessed, as well as the frequency of parameter adjustments.

Results

Twenty‐six participants were included; 100% were using CGM and 81% using AID at baseline. Daily total and bolus insulin, along with carbohydrate input, were significantly reduced by day 7 and remained so, while basal was significantly reduced by day 32. By day 77, there was a median increase in carbohydrate ratios by 4.1% [−1.8, 7.7] and in correction factors by 11.2% [0.0, 20.8], and a reduction in pre‐programmed basal rates by 7.9% [−12.7, −4.2]. The median time spent in hypoglycemia was rarely >4% during these follow‐ups.

Conclusions

Insulin needs decrease rapidly upon initiation of semaglutide use in type 1 diabetes on pump therapy, predominantly due to bolus changes from less carbohydrate consumption. While diabetes technology helps to reduce hypoglycemia, adjustments to pump dosing are still required.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetes Mellitus, Type 1Insulin Infusion SystemsGlucagon-Like PeptidesHypoglycemic AgentsInsulinHumansCross-Over StudiesDouble-Blind MethodFemaleAdultMaleMiddle AgedBlood GlucoseBlood Glucose Self-MonitoringHypoglycemiaGlucagon-Like Peptide 1Semaglutide

Stichwörter der Autor:innen

GLP1 analoguesautomated insulin deliverycontinuous glucose monitoringinsulin pump therapysemaglutidetype 1 diabetes

Substanzen

Glucagon-Like PeptidesHypoglycemic AgentsInsulinBlood GlucoseGlucagon-Like Peptide 1Semaglutide

Autor:innen und Institutionen

  • Division of Endocrinology & Metabolism, McGill University Health Centre, Montreal, Quebec, Canada.
  • The Research Institute of the McGill University Health Centre, Montreal, Quebec, Canada.
  • Division of Experimental Medicine, Department of Medicine, McGill University, Montreal, Quebec, Canada.
  • Department of Biomedical Engineering, McGill University, Montreal, Quebec, Canada.

ORCID-Profile: Melissa-Rosina Pasqua, Michael A Tsoukas, Ahmad Haidar

Förderung

  • Canada Research Chairs

Zitieren

APA

Pasqua, M. R., Tsoukas, M. A., & Haidar, A. (2026). Changes to insulin requirements over time with semaglutide in adults with type 1 diabetes on insulin pump therapy: A post‐hoc analysis of a double‐blinded, randomised, crossover trial. Diabetes, Obesity and Metabolism, 28(1), 427-433. https://doi.org/10.1111/dom.70213

Vancouver

Pasqua MR, Tsoukas MA, Haidar A. Changes to insulin requirements over time with semaglutide in adults with type 1 diabetes on insulin pump therapy: A post‐hoc analysis of a double‐blinded, randomised, crossover trial. Diabetes, Obesity and Metabolism. 2026;28(1):427-433. doi:10.1111/dom.70213

BibTeX
@article{Pasqua2026,
  author = {Pasqua, Melissa-Rosina and Tsoukas, Michael A and Haidar, Ahmad},
  title = {Changes to insulin requirements over time with semaglutide in adults with type 1 diabetes on insulin pump therapy: A post‐hoc analysis of a double‐blinded, randomised, crossover trial},
  journal = {Diabetes, Obesity and Metabolism},
  year = {2026},
  volume = {28},
  number = {1},
  pages = {427--433},
  doi = {10.1111/dom.70213}
}
Kostenlos starten →